{"product_id":"9780124202160","title":"Nonclinical Assessment of Abuse Potential for New Pharmaceuticals","description":"\u003ci\u003eNonclinical Assessment of Abuse Potential for New Pharmaceuticals\u003c\/i\u003e offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, \u003ci\u003eNonclinical Assessment of Abuse Potential for New Pharmaceuticals\u003c\/i\u003e is your single resource for everything you need to know to understand and implement the assessment of abuse liability.\u003cul\u003e\n\u003cli\u003eProvides a consolidated overview of the complex regulatory landscape\u003c\/li\u003e\n\u003cli\u003eOffers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies\u003c\/li\u003e\n\u003cli\u003eIncludes real-life examples to illustrate how nonclinical data fit into the submission strategy \u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Elsevier Science","offers":[{"title":"Default Title","offer_id":47108464279792,"sku":"9780124202160","price":149.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9780124202160_p0.jpg?v=1763639161","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9780124202160","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}